Phoenix Financial Ltd. filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 56,550,148.77 ordinary shares of Teva Pharmaceutical Industries Ltd. as of November 4, 2026.
Key Highlights
- Total beneficial ownership: Phoenix Financial Ltd. reported aggregate beneficial ownership of 56,550,148.77 ordinary shares, representing 4.85% of the class.
- ADS component: According to the filing, 34,785,467 of the reported shares are held in the form of American depositary shares, with each ADS representing one ordinary share.
- Shares outstanding basis: The 4.85% figure is based on 1,166,826,784 ordinary shares outstanding as of November 6, 2026, as reported on Bloomberg LP.
- Largest single holding block: Partnership for Israeli shares held 42,673,972.20 ordinary shares, representing 3.66% of total ordinary shares outstanding.
- Voting and dispositive power: Phoenix Financial reported 0 sole voting or dispositive power, with all 56,550,148.77 shares held under shared voting and shared dispositive power.
- Triggering event date: The event requiring the filing occurred on November 4, 2026.
Phoenix Financial's Disclosed Holdings Across Teva Subsidiaries and Partnerships
According to the amended Schedule 13G, Phoenix Financial Ltd., an Israel-incorporated holding company, reported that the ordinary shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) disclosed in this filing are beneficially owned by various direct or indirect, majority or wholly-owned subsidiaries. The filing states that each of these subsidiaries "operates under independent management and makes its own independent voting and investment decisions."
The filing itemizes the holdings as of November 4, 2026 across several entities within the Phoenix group. The Phoenix Investments House trust funds held 12,028,668.57 ordinary shares (1.03% of outstanding shares). Phoenix "nostro" accounts held 1,114,432 ordinary shares (0.10%). Phoenix pension and provident funds held 256,280 ordinary shares (0.02%). Linked insurance policies of Phoenix accounted for 433,127 ordinary shares (0.04%). The largest block, 42,673,972.20 ordinary shares (3.66%), was held by the Partnership for Israeli shares, with an additional 43,669 ordinary shares (0.00%) held by the Partnership for investing in shares indexes. The filing notes that all ownership rights in these partnerships belong to companies that are part of Phoenix Group, and that "the amount of ownership rights held by such companies in the partnership changes frequently according to a mechanism provided in the partnership agreement."
The filing further states that neither Phoenix Financial nor its subsidiaries admit to being members of a group under Section 13(d) of the Securities Exchange Act of 1934, and each disclaims beneficial ownership beyond their actual pecuniary interest. Phoenix Financial is described as a parent holding company and is organized under the laws of Israel, with its principal office at Derech Hashalom 53, Givataim, 53454, Israel. The filing was signed by two executive vice presidents on November 16, 2026.
What Was Disclosed
Phoenix Financial Ltd. filed Amendment No. 1 to Schedule 13G disclosing aggregate beneficial ownership of 56,550,148.77 Teva ordinary shares, equal to 4.85% of the class, held across multiple subsidiaries and partnerships as of November 4, 2026.





Please wait processing your request...